Alfasigma USA Acquires Zelnorm™
July 8, 2019
Alfasigma USA has acquired the brand ZELNORM (tegaserod), a treatment for IBS-C, from Sloan Pharma, with the aim to relaunch the brand in the United States.
News & Media / Newsroom
Latest news
Alfasigma Spa, corporate announcement
September 7, 2017
The merger between the 3 Italian companies Alfa Wassermann, Sigma-Tau and Biofutura within Alfasigma SpA has been announced last August 1st.
Alfasigma expands its footprints in the U.S. through the acquisition of Pamlab
January 13, 2017
Alfasigma announces the acquisition of Pamlab, a U.S. based company with a leading position in the manufacturing and distribution of medical foods, from Nestlé Health Science.
Alfasigma, the new italian pharmaceutical entity is born
May 18, 2015
Over the last few days the operation foreseeing the transfer into the new holding company Alfasigma of the whole pharmaceutical activities and subsidiaries belonging to both Alfa Wassermann and Sigma-Tau, two of the most prominent Italian Pharmaceutical companies, has been fulfilled.
Lauch of the industrial partnership between Alfa Wassermann and Sigma Tau
March 5, 2015
Alfa Wassermann and Sigma-Tau, two of the most important Italian pharmaceutical Groups, with strong international presence, signed an agreement to create a new company where each of them will contribute its pharmaceutical business.